-
Biologics: Targets & Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets & Therapy
(605,002) Views
Editor in Chief Dr Doris Mangiaracina Benbrook
1177-5475
ISSN 1177-5491 (Online)
ISSN 1177-5475 (Print)
An international, peer-reviewed journal focusing on the patho-physiological rationale for and clinical application of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.
Indexed online in:
- PubMed Central (Biologics)
- American Chemical Society's 'Chemical Abstracts Service' (CAS)
- EMBase, Scopus and the Elsevier Bibliographic databases
- OAIster: The Open Access Initiative
- ResearchGATE scientific network
Article Processing Statistics:
12 From submission of manuscript to first editorial decision (including peer-review)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
